<?xml version="1.0" encoding="UTF-8"?>
<ref id="B64-marinedrugs-17-00373">
 <label>64.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yim</surname>
    <given-names>J.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>S.Y.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>W.G.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>P.S.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>C.K.</given-names>
   </name>
  </person-group>
  <article-title>
   <italic>In vitro</italic> inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03
  </article-title>
  <source>Antivir. Res.</source>
  <year>2012</year>
  <volume>93</volume>
  <fpage>253</fpage>
  <lpage>259</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2011.12.006</pub-id>
  <?supplied-pmid 22197247?>
  <pub-id pub-id-type="pmid">22197247</pub-id>
 </element-citation>
</ref>
